Skip to content

Brazilian Green Propolis pharmacokinetics study in healthy volunteers

Brazilian Green Propolis pharmacokinetics study in healthy volunteers - Brazilian Green Propolis pharmacokinetics study in healthy volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032818
Enrollment
10
Registered
2018-09-30
Start date
2018-06-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult

Interventions

Brazilian Green Propolis containing food(1) Intake: 1,275mg Ingesion:once Brazilian Green Propolis containing food(2) Intake:1,425mg Ingesion:once

Sponsors

Yamada Bee Company, Inc.
Lead Sponsor
Research Center for Immunological Analysis. Inc.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The subjects who meet all of the following criteria are included in this study. 1) Healthy Japanese 2) Males and females from 20 to 45 years old (at the time of consent acquisition) 3) BMI 18.5-25.0 4) Volunteers who is capable to understand and sign the informed consent

Exclusion criteria

Exclusion criteria: The subjects in conflict with any of the following condition are excluded. 1) A person who has a previous history of allergy 2) A person who has a previous history of asthma 3) A woman who is pregnant, hope for the pregnancy, or breastfeeding 4) A person who participated in other clinical trial within 12 weeks prior to ingestion of experimental diet 5) A person who has a positive reaction on the trial for infectious disease at screening 6) A person with a history of the surgery considerable in the gastrointestinal tract site, for example, gastrectomy, stomach and intestines suturation, intestinal tract resection and so on. (not included appendectomy) 7) A person who has a disease of liver, kidney and heart, diabetes and serious desease 8) A person who has received medical treatment of drug 9) A person who can not visit the designated inspection date (including the previous night) and be hospitalized until the end of a trial. 10) A person who can not quit eating and drinking excluding the designated food the day before the trial to the end of a trial. 11) A person who can not quit smoking from dinner the day before the trial to the end of a trial. 12) A person who cannot take in experimental diet according to instruction or cannot maintain rest until the end of a trial. 13) A person who can not ban the intake of propolis containing food within one week prior to the clinical trial. 14) A person who cannot keep regular hours 15) A person who is not daily service (who is night duty or rotating shift) 16) A person who has taken a blood sample (such as blood donation) of more than 200 mL within 4 weeks or more than 400 mL within 3 months prior to the start of this trial 17) A person who is a heavy alcohol drinker (over 500 mL per day in beer) 18) A person who is a heavy smorker (over 20 cigarettes per day) 19) A person who are judged inappropriate as the subject by the principal investigator or subinvestigators.

Design outcomes

Primary

MeasureTime frame
We confirm pharmacokinetics of Propolis metabolites by measuring a blood level of the metabolites before and 0.5,1,1.5,2,4,8,12,24 h after intake of Propolis.

Secondary

MeasureTime frame
We confirm safety by integrating adverse events, physiological examination, hematological examination, blood biochemical examination, and urinalysis (Measuring before and 24 h after intake of Propolis.).

Countries

Japan

Contacts

Public ContactHidenori Matsuzaki

Yamada Bee Company, Inc. Institute for Bee Products & Health Science

hm1380@yamada-bee.com0868-54-3825

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026